DE3579673D1 - Polyazaheterozyklische abkoemmlinge, verfahren zu deren herstellung sowie arzneimittelzusammensetzung. - Google Patents

Polyazaheterozyklische abkoemmlinge, verfahren zu deren herstellung sowie arzneimittelzusammensetzung.

Info

Publication number
DE3579673D1
DE3579673D1 DE8585901549T DE3579673T DE3579673D1 DE 3579673 D1 DE3579673 D1 DE 3579673D1 DE 8585901549 T DE8585901549 T DE 8585901549T DE 3579673 T DE3579673 T DE 3579673T DE 3579673 D1 DE3579673 D1 DE 3579673D1
Authority
DE
Germany
Prior art keywords
polyacaheterocyclic
production
medicinal composition
combination blades
blades
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585901549T
Other languages
English (en)
Inventor
Yoshinao Tsuda
Tadashi Mishina
Minoru Obata
Aza-Azema Araki
Jun Inui
Tadao Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Application granted granted Critical
Publication of DE3579673D1 publication Critical patent/DE3579673D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585901549T 1984-03-12 1985-03-07 Polyazaheterozyklische abkoemmlinge, verfahren zu deren herstellung sowie arzneimittelzusammensetzung. Expired - Fee Related DE3579673D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59047357A JPS60193990A (ja) 1984-03-12 1984-03-12 新規なポリアザ複素環誘導体
PCT/JP1985/000115 WO1985004172A1 (en) 1984-03-12 1985-03-07 Polyazaheterocyclic derivatives, process for their preparation, and pharmaceutical composition

Publications (1)

Publication Number Publication Date
DE3579673D1 true DE3579673D1 (de) 1990-10-18

Family

ID=12772879

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585901549T Expired - Fee Related DE3579673D1 (de) 1984-03-12 1985-03-07 Polyazaheterozyklische abkoemmlinge, verfahren zu deren herstellung sowie arzneimittelzusammensetzung.

Country Status (4)

Country Link
EP (1) EP0183848B1 (de)
JP (1) JPS60193990A (de)
DE (1) DE3579673D1 (de)
WO (1) WO1985004172A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
EP0217142A3 (de) * 1985-09-30 1988-01-07 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocyclische Verbindung
US4746656A (en) * 1986-07-21 1988-05-24 E. R. Squibb & Sons, Inc. 1,2,4,7-tetrahydro-2-oxopyrazolo[1,5-a]pyrimidine derivatives
DE3627411A1 (de) * 1986-08-13 1988-02-18 Bayer Ag Triazolo-pyrimidin-2-sulfonamide
US5260285A (en) * 1990-12-07 1993-11-09 Merck & Co., Inc. Substituted imidazopyridazines as angiotensin II antagonists
US5250521A (en) * 1990-12-07 1993-10-05 Merck & Co., Inc. Substituted pyrazolopyrimidines as angiotensin II antagonists
CA2057089A1 (en) * 1990-12-07 1992-06-08 Eric E. Allen Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists
US6274587B1 (en) 1999-11-19 2001-08-14 Abbott Laboratories Tricyclic dihydropyrimidine potassium channel openers
US6538000B1 (en) 1999-11-19 2003-03-25 Abbott Laboratories Tricyclic dihydropyrimidine potassium channel openers
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
US7772232B2 (en) 2004-04-15 2010-08-10 Bristol-Myers Squibb Company Quinazolinyl compounds as inhibitors of potassium channel function
US20090012103A1 (en) 2007-07-05 2009-01-08 Matthew Abelman Substituted heterocyclic compounds
RU2537295C1 (ru) * 2013-11-01 2014-12-27 Общество с ограниченной ответственностью "Уральский центр биофармацевтических технологий" 4-(2-ГИДРОКСИЭТОКСИ)МЕТИЛ)-5-МЕТИЛ-2-МЕТИЛМЕРКАПТО-1,2,4-ТРИАЗОЛО[1,5-a]ПИРИМИДИН-7(4Н)-ОН - ВЕЩЕСТВО, ОБЛАДАЮЩЕЕ ПРОТИВОВИРУСНЫМ ДЕЙСТВИЕМ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ ПРОТИВ ВОЗБУДИТЕЛЯ ЛИХОРАДКИ ЗАПАДНОГО НИЛА
RU2654463C1 (ru) * 2017-04-21 2018-05-18 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) Энантиомеры 6-этоксикарбонил-7-(тиен-2-ил)-5-метил-4,7-дигидро-1,2,4-триазоло[1,5-а]пиримидина и 6-этоксикарбонил-7-фенил-5-метил-4,7-дигидро-1,2,4-триазоло[1,5-а]пиримидина, обладающие туберкулостатической активностью

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920654A (en) * 1974-03-14 1975-11-18 Dow Chemical Co Methyl-(4-methylphenyl)-substituted-tetra-zolo(1,5-a)pyrimidine
JPS54160745A (en) * 1978-06-06 1979-12-19 Mochida Pharm Co Ltd Circulatory disease treating agent
DE3124718A1 (de) * 1981-06-24 1983-01-13 Boehringer Ingelheim KG, 6507 Ingelheim Neue imidazo (1,2-a)pyramidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
JPH0576086A (ja) * 1991-09-11 1993-03-26 Matsushita Electric Ind Co Ltd 通信装置

Also Published As

Publication number Publication date
EP0183848A4 (de) 1987-10-27
JPS60193990A (ja) 1985-10-02
WO1985004172A1 (en) 1985-09-26
JPH0417198B2 (de) 1992-03-25
EP0183848A1 (de) 1986-06-11
EP0183848B1 (de) 1990-09-12

Similar Documents

Publication Publication Date Title
DE3766878D1 (de) Prothesenteil sowie verfahren zu seiner herstellung.
DE3585069D1 (de) Biologisch degradierbare form und verfahren zu deren herstellung.
DE3681261D1 (de) Pyrrolo-pyrrol pigmentpraeparate, verfahren zu deren herstellung sowie ihre verwendung.
DE3768338D1 (de) Zusammensetzung, verfahren zur deren herstellung und schichtstoff.
DE3673073D1 (de) Therapeutische brausemischung sowie verfahren zu deren herstellung.
DE3577552D1 (de) Vitamin d-derivate und verfahren zu deren herstellung.
DE3860769D1 (de) Polymer-zusammensetzung, verfahren zu deren herstellung und deren anwendung.
DE3586822D1 (de) Halbleiteranordnung und verfahren zu deren herstellung.
DE3581563D1 (de) Polysiloxanpfropfcopolymer und verfahren zu dessen herstellung.
DE3582576D1 (de) Dithioketo-pyrrolo-pyrrole, verfahren zu deren herstellung und verwendung.
DE3577590D1 (de) Keramisch-metallische verbindung und verfahren zu deren herstellung.
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
DE3577103D1 (de) Thermoplastische massen auf basis von polyphenylenethern und polyoctenylenen sowie verfahren zu ihrer herstellung.
DE3580487D1 (de) Aromatische aminosulfonverbindungen und verfahren zu deren herstellung.
DE3778148D1 (de) Zusammensetzungen mit discorhabdin, sowie verfahren zu deren verwendung.
DE3579436D1 (de) Tetrahydrochinolin- derivate, verfahren zu deren herstellung und diese enthaltende antimagengeschwuerzusammensetzungen.
DE3579673D1 (de) Polyazaheterozyklische abkoemmlinge, verfahren zu deren herstellung sowie arzneimittelzusammensetzung.
DE3574475D1 (de) Dextranhexonsaeureverbindung, komplex mit ferrihydroxyd und verfahren zu deren herstellung.
DE3670304D1 (de) Hitzebestaendige gelbpigmente, verfahren zu ihrer herstellung sowie deren verwendung.
DE3677740D1 (de) 2-iod-perfluor-2-methylalkane, verfahren zu deren herstellung und deren verwendung.
DE3219380A1 (de) Anthracyclinglycosid-verbindungen, verfahren zu deren herstellung, zwischenverbindungen und verfahren zu deren herstellung sowie pharmazeutisches mittel
DE3686235D1 (de) Hitzebestaendige zusammensetzung und verfahren zu deren herstellung.
DE58903212D1 (de) Eisenoxidpigmente, verfahren zu ihrer herstellung sowie deren verwendung.
DE3482258D1 (de) 2,2-difluorpropionsaeurederivate und verfahren zu ihrer herstellung.
DE58902448D1 (de) Hitzestabile eisenoxidschwarz-pigmente, verfahren zu ihrer herstellung sowie deren verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee